Related Experiment Video
Updated: Jun 8, 2026
08:25
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
Elevated epidermal ornithine decarboxylase activity suppresses contact hypersensitivity
Martin P Keough1, Candace S Hayes, Karen DeFeo
1Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA.
The Journal of Investigative Dermatology
|September 17, 2010
Summary
Elevated epidermal ornithine decarboxylase (ODC) activity suppresses skin immunity by reducing key cytokines, hindering immune cell migration and infiltration. Inhibiting ODC restored normal contact hypersensitivity responses in mice.
Area of Science:
- Immunology
- Dermatology
- Biochemistry
Background:
- Elevated polyamine biosynthesis is linked to skin tumorigenesis.
- Epidermal ornithine decarboxylase (ODC) is a key enzyme in polyamine biosynthesis.
- ODC activity's role in cutaneous immunity is not fully understood.
Purpose of the Study:
- To investigate the effect of epidermal ODC overexpression on the contact hypersensitivity (CHS) response.
- To determine if increased ODC activity suppresses the cutaneous immune response.
Main Methods:
- Utilized an ODCER transgenic mouse model with epidermal ODC overexpression.
- Assessed CHS response, including ear swelling and immune cell infiltration.
- Measured cytokine levels and dendritic cell (DC) migration.
- Employed adoptive transfer experiments and an ODC inhibitor (α-difluoromethylornithine).
Main Results:
- ODCER transgenic mice exhibited reduced ear swelling, neutrophil infiltration, and DC migration compared to controls.
- Epidermal ODC overexpression suppressed levels of key cytokines (KC, MCP-1, IL-6, IL-10).
- Elevated epidermal ODC activity suppressed both sensitization and elicitation phases of CHS.
- ODC inhibition abrogated the suppressive effects on CHS.
Conclusions:
- Increased epidermal ODC activity suppresses the cutaneous immune response, specifically CHS.
- Immunosuppression is mediated by reduced cytokine levels, impairing DC migration and immune cell infiltration.
- Targeting ODC may offer therapeutic potential for inflammatory skin conditions.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:09Epistasis Analysis
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...